Loading...
A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy
Breast cancer is the most common cancer in women worldwide. A new promising anti-cancer therapy involves the use of monoclonal antibodies specific for target tumor-associated antigens (TAAs). A TAA of interest for immunotherapy of Triple Negative Breast Cancer (TNBC) is nucleolin (NCL), a multifunct...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5349967/ https://ncbi.nlm.nih.gov/pubmed/27894092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13522 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|